Study Detail

Repurposing FDA-Approved Drugs for Treatment of 2019-nCoV-induced Disease

Genetics of susceptibility and mortality in critical care

Status: not available

Type: Pre-clinical

Funder: NIHR/UKRI

Sponsor: Queens University Belfast

CI: Professor Ultan Power

IRAS-Number: Pre-clinical

CPMS-ID: not available

Approval Date: 11 March 2020

Back to listing